Grasse-Backed Bill Defends Science, Reaffirms Support for Evidence-Based Immunizations

ARLINGTON HEIGHTS, Ill — Working to defend public health and modern medicine against pseudoscience touted from Washington, state Rep. Nicolle Grasse, D-Arlington Heights, helped pass a new law to establish\immunization guidelines and require Illinois Department of Public Health-recommended (IDPH) vaccines be covered by health insurance.

“Healthcare policy should be dictated by science, not the whims of unqualified conspiracy theorists,” Grasse said. “Modern vaccines are marvels of science that have saved millions of lives, and we should be doing everything in our power to ensure individuals’ rights to protect themselves and others from infectious diseases.”

House Bill 767 establishes transparent, evidence-based immunization guidelines for Illinois and reaffirms the state’s commitment to defending science. To keep vaccines accessible and affordable to those who seek them, the bill will require vaccinations recommended by IDPH to be fully covered by state-regulated health insurance plans.

Additionally, under the measure, experts will make up a new Illinois Immunization Advisory Committee to ensure all recommendations are rooted in science. With heightened claims from the federal government and Centers for Disease Control and Prevention (CDC) grossly linking vaccines to autism, House Bill 767 critically ensures that immunization recommendations are being made by medical experts to thwart sickness and diseases for unvaccinated and vaccinated individuals—not politicians out of Washington.

“In Illinois, we listen to science and reason, and we’re not going to fight experts who have dedicated their lives to public health. These protections ensure residents can make the choices that are right for them and their families, and prevent common-sense vaccinations from being blocked behind a paywall,” Grasse said.

House Bill 767 was signed into law Tuesday and is effective immediately, with insurance changes to be effective January 1 of next year.